South Korea Extends Task Force To Crack Down On Illegal Kickbacks
This article was originally published in PharmAsia News
Executive Summary
The team of prosecutors, health ministry officials and Korea FDA officials was renewed for one more year to investigate the deep-rooted practice in the pharma and device sectors.
You may also be interested in...
Korea's Antitrust Watchdog Says Rebates Continuing Despite New Law; Levies $11 Million In Fines
SEOUL - South Korea's antitrust watchdog the Fair Trade Commission said rebates by both multinational and local Korean pharmaceutical companies are continuing even though doctors can be punished for accepting rebates under a new law that took effect late last year
Korean Government Launches Strongest-ever Drive To Root Out Rebates
SEOUL - In the strongest ever all-out government crackdown on rebates between hospital doctors and pharmaceutical companies, the Korean government established a joint task force at a Seoul Prosecution Office that it hopes will add teeth to better enforce anti-rebate laws implemented last November
Korea Targets Biologics, Devices, Health Care Among Economic Growth Projects For Next Decade
SEOUL - South Korean President Lee Myung-bak named "17 new growth engines" at a science and technology council meeting at his office in Seoul Jan. 13. Expected to spearhead the country's economic growth for the next 10 years, of those 17 economic growth engines, the Korean government targeted biologics, medical devices and global health care among the national priorities